Futures
Access hundreds of perpetual contracts
CFD
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
CFD
U.S. stock CFD derivatives
US Stocks
Access real US stocks and ETFs
HK Stocks
Trade quality Hong Kong-listed stocks
Korean Stocks
SK Hynix
Real Korean stocks and top assets
Stock Futures
High leverage, 24/7 trading
Tokenized Stocks
Backed by real stock assets
IPO Access
Unlock full access to global stock IPOs
GUSD
3.8%
Mint GUSD for Treasury RWA yields
Stocks Activities
Trade Popular Stocks and Unlock Generous Airdrops
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
IPO Access
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
AI infrastructure, Gate MCP, Skills, and CLI
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
Healing Reproductive Medicine Center suspected of mixing up embryo samples
The Chairman of the Human Reproductive Technology Administration, Leung Hin-sun, said that the Shei Yu Reproductive Medicine Centre had a suspected mix-up involving embryo samples. During the check-up process for artificial insemination, the centre sent the embryo samples to the Chinese University laboratory for genetic testing. It was found that the samples extracted from the embryos were suspected to have been confused and were not from the original parents. The incident involves two cases. The Administration considers the situation serious and has reported it to the police for handling.
The Administration said that after it received a report from the Chinese University laboratory last month, it conducted an on-site inspection of the centre. After meeting with the doctors involved, it believed there were no procedural errors and that the medical records were fine. It was possible that, during the process of submitting the samples for testing, samples that did not belong to the parents were inserted. After checks, the possibility of embryo mix-up was ruled out, pending further investigation into whether human factors were involved. The purpose of the testing is to extract embryo samples, select normal and healthy embryos, and place them into the mother. If the testing were to be mixed up, there is a risk that abnormal embryos could be placed into the mother.
The Department of Health said that the centre did not report the incident within 24 hours. The department has issued a regulatory notice requiring the centre to submit an investigation report within four weeks, explaining the cause of the incident and the improvement measures, and requiring it to suspend receiving new cases. The authorities have suspended 14 items of services at the centre. The centre is responsible for referring the cases to other centres for follow-up.